ADELAIDE, SOUTH AUSTRALIA, 20 December 2016 – Complexica Pty Ltd, a leading provider of Artificial Intelligence software, announced today that it has signed a contract with Boehringer Ingelheim for the deployment of its What-if Simulator, powered by Larry, the Digital Analyst®.
“Like most innovative multi-national companies, Boehringer Ingelheim operates in a dynamic environment that has many moving parts,” said Jon Simpson, Head of Sales for Boehringer Ingelheim Australia and New Zealand. “Conducting timely and accurate data analysis is often a challenging and time-consuming endeavour, which requires significant human expertise. Complexica’s What-if Simulator, powered by Larry, the Digital Analyst, is ideally suited for the analytical challenges within our business and operating environment.”
Boehringer Ingelheim is one of the world's top 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany for over 130 years the family-owned company has been committed to researching, developing, manufacturing, and marketing new medicines of high therapeutic value for human and veterinary medicine. In Australia, Boehringer Ingelheim operates in the key business areas of Prescription Medicine and Animal Health. For more information about Boehringer Ingelheim, please visit: www.boehringer-ingelheim.com.au
Larry joins Boehringer Ingelheim’s workforce as a Digital Analyst, tasked with analysing large internal and external datasets to answer complex what-if questions. In particular, Larry will help Boehringer Ingelheim to:
- Answer complex what-if questions that contain many variables and “moving parts” that impact one another in a probabilistic manner
- Investigate a variety of assumptions and hypothesis that are difficult to test in the real-world
- Compare the outcome of various what-if scenarios and analyse the key drivers behind the differences
- Understand the deterministic and non-deterministic factors present in the operations of the business
